These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

482 related items for PubMed ID: 1609773

  • 1. A probable double heterozygous type II von Willebrand's disease with increased ristocetin induced platelet aggregation.
    Kinoshita S, Yoshioka K, Kasahara M, Takamiya O.
    Am J Hematol; 1992 Jul; 40(3):192-8. PubMed ID: 1609773
    [Abstract] [Full Text] [Related]

  • 2. A new von Willebrand variant (type I, New York): increased ristocetin-induced platelet aggregation and plasma von Willebrand factor containing the full range of multimers.
    Weiss HJ, Sussman II.
    Blood; 1986 Jul; 68(1):149-56. PubMed ID: 3487353
    [Abstract] [Full Text] [Related]

  • 3. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
    Michiels JJ, van de Velde A, van Vliet HH, van der Planken M, Schroyens W, Berneman Z.
    Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
    [Abstract] [Full Text] [Related]

  • 4. Laboratory diagnosis and molecular classification of von Willebrand disease.
    Gadisseur A, Hermans C, Berneman Z, Schroyens W, Deckmyn H, Michiels JJ.
    Acta Haematol; 2009 Apr; 121(2-3):71-84. PubMed ID: 19506352
    [Abstract] [Full Text] [Related]

  • 5. von Willebrand's disease characterized by increased ristocetin sensitivity and the presence of all von Willebrand factor multimers in plasma.
    Holmberg L, Berntorp E, Donnér M, Nilsson IM.
    Blood; 1986 Sep; 68(3):668-72. PubMed ID: 3488775
    [Abstract] [Full Text] [Related]

  • 6. A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers.
    Casonato A, Pontara E, Dannhäuser D, Bertomoro A, Sartori MT, Girolami A.
    Haematologia (Budap); 1994 Sep; 26(2):97-109. PubMed ID: 7890268
    [Abstract] [Full Text] [Related]

  • 7. Platelet--von Willebrand factor interactions in type IIB von Willebrand's disease.
    Holmberg L, Kristoffersson AC, Lamme S, Nilsson IM, Awidi A, Solum NO.
    Scand J Haematol; 1985 Sep; 35(3):305-14. PubMed ID: 3877338
    [Abstract] [Full Text] [Related]

  • 8. Characterization, classification, and treatment of von Willebrand diseases: a critical appraisal of the literature and personal experiences.
    Michiels JJ, Gadisseur A, Budde U, Berneman Z, van der Planken M, Schroyens W, van de Velde A, van Vliet H.
    Semin Thromb Hemost; 2005 Nov; 31(5):577-601. PubMed ID: 16276467
    [Abstract] [Full Text] [Related]

  • 9. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1.
    Michiels JJ, Gadisseur A, Vangenegten I, Schroyens W, Berneman Z.
    Acta Haematol; 2009 Nov; 121(2-3):119-27. PubMed ID: 19506358
    [Abstract] [Full Text] [Related]

  • 10. Type 2B von Willebrand's disease due to Val1316Met mutation. Heterogeneity in the same sibship.
    Rendal E, Penas N, Larrabeiti B, Pérez A, Vale A, López-Fernández MF, Batlle J.
    Ann Hematol; 2001 Jun; 80(6):354-60. PubMed ID: 11475150
    [Abstract] [Full Text] [Related]

  • 11. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
    Michiels JJ, van Vliet HH, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, van der Velden A, Budde U.
    Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
    [Abstract] [Full Text] [Related]

  • 12. New variant of type II von Willebrand's disease with structural abnormality of plasma von Willebrand factor in a patient with very mild bleeding history.
    Baillod P, Gaucher C, Affolter B, Mazurier C, Pflugshaupt R.
    Am J Hematol; 1995 May; 49(1):21-8. PubMed ID: 7741134
    [Abstract] [Full Text] [Related]

  • 13. Investigation of a case of subtype IIC von Willebrand disease: characterization of the variability of this subtype.
    Mazurier C, Mannucci PM, Parquet-Gernez A, Goudemand M, Meyer D.
    Am J Hematol; 1986 Jul; 22(3):301-11. PubMed ID: 3087159
    [Abstract] [Full Text] [Related]

  • 14. A new L1446P mutation is responsible for impaired von Willebrand factor synthesis, structure, and function.
    Casonato A, Cattini MG, Soldera C, Marcato S, Sartorello F, Pontara E, Pagnan A.
    J Lab Clin Med; 2004 Nov; 144(5):254-9. PubMed ID: 15570243
    [Abstract] [Full Text] [Related]

  • 15. Heterogeneity of type I von Willebrand disease: evidence for a subgroup with an abnormal von Willebrand factor.
    Mannucci PM, Lombardi R, Bader R, Vianello L, Federici AB, Solinas S, Mazzucconi MG, Mariani G.
    Blood; 1985 Oct; 66(4):796-802. PubMed ID: 3876122
    [Abstract] [Full Text] [Related]

  • 16. Response to desmopressin in type IID von Willebrand's disease.
    Thomas N, O'Callaghan U, Lowe GD, Olszynski V, Kernoff PB, Abildgaard CF, Tuddenham EG.
    Clin Lab Haematol; 1989 Oct; 11(3):189-97. PubMed ID: 2591151
    [Abstract] [Full Text] [Related]

  • 17. Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry.
    Giannini S, Mezzasoma AM, Leone M, Gresele P.
    Haematologica; 2007 Dec; 92(12):1647-54. PubMed ID: 18055988
    [Abstract] [Full Text] [Related]

  • 18. Reduced von Willebrand factor survival in type Vicenza von Willebrand disease.
    Casonato A, Pontara E, Sartorello F, Cattini MG, Sartori MT, Padrini R, Girolami A.
    Blood; 2002 Jan 01; 99(1):180-4. PubMed ID: 11756169
    [Abstract] [Full Text] [Related]

  • 19. Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor.
    Grainick HR, Williams SB, McKeown LP, Rick ME, Maisonneuve P, Jenneau C, Sultan Y.
    J Clin Invest; 1985 Oct 01; 76(4):1522-9. PubMed ID: 2932469
    [Abstract] [Full Text] [Related]

  • 20. Type 2M von Willebrand disease variant characterized by abnormal von willebrand factor multimerization.
    Casonato A, Pontara E, Sartorello F, Bertomoro A, Durante C, Girolami A.
    J Lab Clin Med; 2001 Jan 01; 137(1):70-6. PubMed ID: 11150026
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.